$20.50
-0.40-1.91%
At close: Nov 11, 4:00 PM EST
$20.50
-0.40-1.91%
Pre-Market: 4:00 AM EST
Braveheart Bio Inc (BRVE) Stock Price, Quote, News & History
BRVENASDAQ
You can purchase shares of Braveheart Bio (NASDAQ:BRVE) through any online brokerage.
Other companies in Braveheart Bio’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Braveheart Bio has a consensus price target of $45.25.
The stock price for Braveheart Bio (NASDAQ: BRVE) is $20.5 last updated November 12, 2026 at 4:26 PM EST.
There are no upcoming dividends for Braveheart Bio.
Braveheart Bio does not have any upcoming earnings scheduled.
There is no upcoming split for Braveheart Bio.
Braveheart Bio is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Braveheart Bio Inc is a clinical-stage biotechnology company focused on developing therapeutics to treat hypertrophic cardiomyopathy (HCM) and other cardiovascular diseases. Its flagship product candidate, BHB-1893, is an oral small-molecule cardiac...
